Myomo(MYO) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Myomo Reports Second Quarter 2024 Financial Results Record revenue of $7.5 million Record 213 MyoPro® authorizations and orders Record 550 additions to the pipeline, with 1,179 patients in the pipeline at quarter-end BOSTON (August 6, 2024) – Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upperlimb paralysis, today announced financial results for the three an ...